Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04062266
Title Azacitidine and Venetoclax in Treating Patients With High Risk Acute Myeloid Leukemia in Remission
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

Therapies

Azacitidine + Venetoclax

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST